Pearl Therapeutics Receives Award for Innovative Co-Suspension Technology Leading drug delivery companies and scientists recognize Pearl’s technical innovation REDWOOD CITY, CALIF., March 14, 2013 – Pearl Therapeutics Inc. today announced their receipt of the...
Douglas Harrington, MD Addresses Select Group of Physicans Regarding Latest Advances in Cardiovascular Risk Assessment MARCH 19, 2013 (San Francisco, CA) – Aviir Inc., a biotechnology company dedicated to enhanced detection and prevention of cardiovascular disease...
NeuroStar TMS Therapy, a Non-Drug Depression Treatment, Demonstrates Statistically Significant Benefits on Patient-Reported Pain Outcomes Study Participants Experienced Improvement in Pain and Well-Being that Persisted Through One Year SAN DIEGO, March 19, 2013 – New...
Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer Hematology / oncology industry expert to lead promising development pipeline BOULDER, Colo., March 21, 2013 /PRNewswire/ — Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company...
VaxInnate Awarded U.S. Government Grant to Develop Dengue Vaccine Mosquito-borne disease identified as emerging public health threat for Americans CRANBURY, NJ, April 4, 2013 – VaxInnate Corporation announced today that it has been awarded a grant by the National...
Recent Comments